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Notch signaling regulates Hey2 
expression in a spatiotemporal 
dependent manner during cardiac 
morphogenesis and trabecular 
specification
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Hey2 gene mutations in both humans and mice have been associated with multiple cardiac defects. 
However, the currently reported localization of Hey2 in the ventricular compact zone cannot explain the 
wide variety of cardiac defects. Furthermore, it was reported that, in contrast to other organs, Notch 
doesn’t regulate Hey2 in the heart. To determine the expression pattern and the regulation of Hey2, 
we used novel methods including RNAscope and a Hey2CreERT2 knockin line to precisely determine the 
spatiotemporal expression pattern and level of Hey2 during cardiac development. We found that Hey2 
is expressed in the endocardial cells of the atrioventricular canal and the outflow tract, as well as at 
the base of trabeculae, in addition to the reported expression in the ventricular compact myocardium. 
By disrupting several signaling pathways that regulate trabeculation and/or compaction, we found 
that, in contrast to previous reports, Notch signaling and Nrg1/ErbB2 regulate Hey2 expression level 
in myocardium and/or endocardium, but not its expression pattern: weak expression in trabecular 
myocardium and strong expression in compact myocardium. Instead, we found that FGF signaling 
regulates the expression pattern of Hey2 in the early myocardium, and regulates the expression level of 
Hey2 in a Notch1 dependent manner.
Hey2, together with Hey1, HeyL and their presumptive Drosophila homologue, dHey, is a member of a subfamily 
of hairy-related basic helix-loop-helix (bHLH) transcription factors1,2, that are implicated in cell fate determina-
tion and boundary formation3. Hey2 mutations in both humans and mice cause a variety of cardiac morphoge-
netic defects, as well as a cardiomyocyte maturation defect. In humans, non-synonymous sequence changes in 
Hey2 correlate with atrioventricular septal defects and other cardiac defects4,5, and Hey2 duplication contributes 
to both congenital heart defects and neurodevelopmental defects6. Similarly, Hey2 knockout mice display defects 
including atrioventricular valvular defects, pulmonary stenosis, Tetralogy of Fallot, tricuspid atresia, and abnor-
mal cardiac hemodynamics7–9, indicating that Hey2 is an essential regulator of cardiac morphogenesis and cardiac 
function. Furthermore, genome-wide association study associated Hey2 mutation with Brugada syndrome, a rare 
cardiac arrhythmia disorder in humans10.
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Despite profound cardiac defects caused by Hey2 mutation in both humans and mice, the current knowledge 
of the Hey2 expression pattern—that Hey2 is expressed in the compact zone of the myocardium—cannot fully 
explain this broad range of congenital defects. It is unclear how Hey2 enrichment in the ventricular compact 
myocardium could contribute to atrioventricular morphogenesis and semilunar valvular morphogenesis. Using 
an RNAscope, an assay that enables single mRNA molecule detection and is compatible with immunofluorescent 
staining, we were able to determine the cell type- and developmental stage-specific expression pattern of Hey2 at 
the level of single mRNA molecule. Specifically, we found that, in addition to the previously reported expression 
in the ventricular compact myocardium and interventricular septum, Hey2 is also expressed in the endocardial 
cells of the atrioventricular canal (AVC), the outflow tract (OFT), and at the base of trabeculae, as well as in 
pro-epicardial cells and epicardial cells. The expressional level and pattern of Hey2 examined by the RNAScope 
were also consistent with the expression pattern determined by the Hey2CreERT2 knock-in mouse line.
Hey2 functions in cell fate specification and cardiomyocyte maturation. Gridlock/Hey2 is involved in adjudi-
cating an arterial versus venous cell fate decision during the assembly of the first embryonic artery in zebrafish11. 
In mice, cardiac specific Hey2 knockout hearts display ectopic atrial gene expression12,13. Hey2 null cardiomyo-
cytes displayed abnormal mitochondria, abnormal accumulation of glycogen particles, and disorganized myofi-
brils based on transmission electron microscope analysis8. Expression levels of β-MHC and ANF genes in the 
Hey2 knockout are increased8. The phenotypes of Hey2 knockout heart indicate that Hey2 might play roles in 
cardiomyocyte differentiation and maturation.
Previous work has suggested that trabecular cardiomyocytes, which take the major responsibility for pumping 
during the early stages of cardiac development, are more differentiated than the cardiomyocytes of the compact 
zone14. The facts that Hey2 is expressed in the cardiomyocytes of the compact myocardium and that Hey2 disruption 
results in a larger and wider sarcomere suggest that Hey2 might repress cardiomyocyte maturation and might serve 
as a marker for less differentiated and/or less mature cardiomyocytes. Previously, single cell lineage tracing studies 
revealed that asymmetric distribution of Hey2 during cardiomyocyte oriented cell division might contribute to the 
differential expression of Hey2 in compact and trabecular cardiomyocytes15. However, the signaling pathways that 
regulate the Hey2 expression pattern and its asymmetric distribution in a perpendicular oriented cell division during 
trabecular initiation are unknown. To identify the signaling pathways that regulate the differential expression levels 
of Hey2 in the compact zone and the trabecular zone, we assessed the expression of Hey2 in various mutants that are 
defective in several pathways implicated in trabeculation and compaction, including Nrg1/ErbB2/4 and Notch1. We 
found that these mutants showed decreased expression levels of Hey2, but displayed normal enrichment and repres-
sion of Hey2 in the compact zone and trabecular zone, respectively. FGF ligand stimulation changes the expression 
pattern of Hey2 in the ventricles temporally in both in vivo and ex vivo models, resulting in more trabeculation. We 
further found that FGF2 regulates the expression level of Hey2 in a Notch1 dependent manner.
Results
Hey2 is expressed in the endocardial cells of the AVC, OFT and the base of trabeculae in addition 
to its known localization to the compact zone. Previous in situ hybridization (ISH) studies using whole 
embryos or tissue sections demonstrated that Hey2 is expressed in the compact zone, AV cushion, and ventricular 
septum1,16. However, harsh treatment in traditional ISH protocols prevents successful simultaneous immunofluo-
rescence staining, which is necessary to accurately identify the cell types that express Hey2. In this study, we used 
the RNAscope, which can detect single mRNA molecules and allows for ISH and immunofluorescence staining in 
the same samples15, and a Hey2CreERT2 knockin mouse line17, to determine the expression level and pattern of Hey2 
and found a broader expression pattern of Hey2 than previously reported. In both left and right ventricles, Hey2 
is enriched in the outer compact zone (OCZ), and is weakly expressed in the inner compact (ICZ) and trabecular 
zones (Fig. 1a,a1,b and b1). In addition to its expression in the outer compact zone, Hey2 is robustly expressed in 
endocardial cells of the atrioventricular canal (AVC) (Fig. 1a and a2) and outflow tract (OFT) (Fig. 1b and b2) at 
E9.5. Furthermore, Hey2 is weakly expressed in the endocardial cells at the base of trabeculae, and the endocardial 
cells that closely abut the cardiomyocytes contains 6.25 dots/section/cell (n = 6), which is relatively greater than the 
Hey2 expression in endocardial cells that are not adjacent to the cardiomyocytes, which contain 3.20 dots (n = 6) 
(Fig. 1a and a1). We also examined the Hey2 expression pattern by staining with estrogen receptor (ESR) using E9.5 
hearts from Hey2CreERT2 knockin embryos, and consistently Hey2 was strongly expressed in the compact zone and 
in the endocardial cells of the AVC and OFT (Fig. 1c,c2 and c3), and weakly expressed in the cardiomyocytes of 
trabecular zone and the ventricular endocardial cells (Fig. 1c). However, via the ESR staining, we did not observe the 
differential expression of Hey2 in outer and inner compact zone, and its differential expression in ventricular endo-
cardial cells at different regions cannot be distinguished (Fig. 1a–c), which might be due to the detection threshold 
of ESR proteins distingguishable by antibody-mediated immunostaining.
Hey2 is expressed in the mesenchymal cells of the AVC and OFT. Consistently with its expression 
pattern at E9.5, Hey2 is highly expressed in the outer compact zone, endocardial cells of the AVC and OFT, and 
weakly expressed in ventricular endocardial cells in E10.5 hearts (Fig. 2a–c). The endocardial cells that closely 
abut against the cardiomyocytes display more Hey2 compared to the cells that are not adjacent to cardiomyocytes 
(Fig. 2a and a1). Hey2 is also expressed in the cells between endocardial cells and cardiomyocytes, which are mes-
enchymal cells derived from endocardial cells of the AVC (Fig. 2b and b1) and OFT (Fig. 2c and c1), at a lower 
intensity compared to the endocardial cells of the AVC and OFT. Via the Hey2CreERT2, we found that Hey2 is also 
expressed in the endocardial cells and mesenchymal cells of AVC and OFT cushion (Fig. 2d and d1). The expres-
sion of Hey2 in these endocardial cells and cushion tissues might suggest that Hey2 is involved in endocardial cell 
epithelial-mesenchymal transition (EMT) and that Hey2 disruption leads to the valvular morphogenesis defects 
previously reported in Hey2 knockouts16. In addition to its expression in the aforementioned endocardial cells, we 
also found that Hey2 is weakly expressed in pro-epicardial cells and epicardial cells (Figs 1a and 2d).
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Figure 1. Hey2 is expressed in the endocardial cells of the AVC, OFT and the base of trabeculae, in addition 
to its known localization to the compact zone. (a and b) Hey2 expression pattern in E9.5 control heart. Box 
a1,a2 and Box b1,b2 in Figures a,b were zoomed to a1,a2 and b1,b2 on the right. White and green arrows in 
a1,b1 point to the compact zone (OCZ) and inner compact zone (ICZ), respectively. Red and yellow arrows in 
a1 point to endocardial cells that attach or do not attach to cardiomyocytes, respectively. The red arrow in b2 
points to endocardial cells of the OFT. Blue arrow in a points to pro-epicardial organ (PEO). (c) The expression 
pattern of Hey2 via ESR staining using the Hey2CreERT2 mouse line. White and green arrows in c1 point to the 
outer and inner compact zone, respectively. Red and yellow arrows in c1 point to endocardial cells that attach or 
do not attach to cardiomyocytes, respectively. The red arrow in c1 points to endocardial cells of the ventricle. LV: 
Left ventricle; RV: Right ventricle; AVC: Atrioventricular canal; EC: Epicardial cell; PEO: Pro-epicardial organ; 
OFT: Outflow tract; IFT: Inflow tract. Scale bars in (a–c) are 50 μm and 10 μm in zoomed boxes. Representative 
pictures from at least three embryos of each genotype at different ages were shown.
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Notch signaling regulates Hey2 expression in ventricular endocardial cells. Previous work has 
shown that Hey2 expression is altered in Dll1 or Notch1 knockout mice during somitogenesis18,19. However, dur-
ing cardiac morphogenesis, studies have demonstrated that Notch Intracellular Domain (NICD) overexpression 
Figure 2. Hey2 is expressed in the mesenchymal cells of AVC and OFT. (a–c) Hey2 expression pattern in an 
E10.5 control heart via RNAScope. The box regions in (a–c) are zoomed and put to the right. The red arrow 
in a1 points to a cell that closely attaches to cardiomyocytes and displayed more Hey2 molecules than a cell in 
a1 that does not attach to cardiomyocytes, as indicated by a white arrow. White arrows in b1 and c1 point to 
mesenchymal cells that are derived from the AVC and OFT, respectively. (d) The expression pattern of Hey2 
via ESR staining using the Hey2CreERT2 mouse line at E11.5. Green arrows in d point to epicardial cells and 
white arrows in d1 point to the mesenchymal cells that are derived from the endocardial cells of AVC. LV: Left 
ventricle; RV: Right ventricle; AVC: Atrioventricular canal; EC: Epicardial cell; PEO: Pro-epicardial organ; OFT: 
Outflow tract. Scale bars in (a–d) are 50 μm and 10 μm in zoomed boxes. Representative pictures from at least 
three embryos of each genotype at different ages were shown.
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activated Hey1 but not Hey2 expression in the heart using the NICD transgenic line20. Furthermore, Notch2 knock-
out mice displayed normal expression patterns of Hey1 and Hey2 in the myocardium21 and Rbpjk global knockout 
embryos did not alter the expressional level of Hey2 in the heart based on Q-PCR22. These reports indicate that 
Notch signaling does not regulate Hey2 expression in the heart. However, it is possible that Notch signaling reg-
ulates Hey2 expression in some cell types such as endocardial cells that cannot be detected by whole heart RNA 
quantification and traditional ISH. To test this possibility, we examined the expression of Hey2 in different mutants 
via RNAscope coupled with immunofluorescence staining. We used Nfatc1Cre/+, which is specifically expressed 
in the endocardial cells23, to mediate Notch1 deletion, and found reduced NICD expression (Fig. 3a and b). 
Nfatc1Cre/+; Notch1fl/fl knockout hearts showed a slight reduction in Hey2 in the endocardial cells of the AVC at 
E9.5, but did not show obvious reduction of Hey2 in the compact zone (Fig. 3c,c1,d and d1). Due to the incom-
plete deletion of Notch1 at early stages such as E9.5 (Fig. 3a), we examined the knockouts at E10.5 and consistently 
found that Hey2 expression was reduced in the endocardial cells of AVC and also in the endocardial cells that 
closely interact with cardiomyocytes at the base of trabeculae, while Hey2 expression in the compact zone was 
not obviously altered (Fig. 3e,e1,f and f1). Hey2 expression in the endocardial cells of the OFT was not changed 
in the Nfatc1Cre/+; Notch1fl/fl (Data not shown). The difference in expression of Hey2 between control and knock-
out hearts was not as large as expected, which might be due to late expression of Cre in the Nfatc1Cre/+ mouse 
(Fig. 3a,b). Therefore, we used Tie2Cre, which is expressed starting at E7.5, to delete Notch1 in endocardial cells. 
This knockout died at around E10.5 and displayed a trabeculation defect as previously reported24. Hey2 expres-
sion in the endocardial cells of this knockout was significantly reduced at E9.5 (Fig. 3g,g1,h and h1). To determine 
if other Notch receptors in addition to the Notch1 receptor regulate Hey2 in endocardial cells, we examined the 
expression of Hey2 in Tie2Cre-mediated Rbpjk knockout hearts. Surprisingly, the Hey2 expression level in the 
endocardial cells of the Tie2Cre; Rbpjkfl/fl knockout was not obviously different from that of the Tie2Cre; Notch1fl/fl  
knockout (Suppl. Figure 1a,b), suggesting that Notch1 is the major receptor in endocardial cells that regulates 
Hey2 expression. The incomplete abolishment of Hey2 expression in the endocardial cells, especially those of 
the AVC in Tie2Cre; Rbpjkfl/fl knockouts, indicates that an Rbpjk-independent signaling pathway also regulates 
Hey2 expression in the endocardium. We examined total Hey2 in control and Tie2Cre; Rbpjkfl/fl knockout hearts 
via Q-PCR and found that the knockouts displayed higher levels of Hey2 (Suppl. Figure 1c), possibly due to a 
relatively smaller trabecular zone and a larger compact zone, where Hey2 is enriched.
Notch signaling regulates the expression level but not the pattern of Hey2 in the myocardium. 
Echocardiographic studies of Hey2 knockout mice revealed reduced left ventricular contractile function8. It is 
speculated that the presence of abnormal cardiomyocytes accounts for the decreased left ventricle fractional 
shortening, indicating the importance of Hey2 in compact zone cardiomyocyte maturation. The signaling path-
ways that regulate the enrichment of Hey2 in the compact zone and the low abundance in the trabecular zone 
have not been reported before. Our data showed that Notch1 or Rbpjk deletion in endocardial cells via Nfatc1Cre/+ 
or Tie2Cre did not affect the Hey2 enrichment in the compact zone (Fig. 3), indicating that Notch signaling in 
the endocardium does not regulate Hey2 in the myocardium non-autonomously—as it does with many other 
factors in the myocardium24,25. We then investigated if Notch1 and Rbpjk regulate Hey2 in the compact zone 
autonomously by examining Hey2 expression in the myocardium of both Nkx2.5Cre/+; Notch1fl/fl and Nkx2.5Cre/+; 
Rbpjkfl/fl knockouts. Nkx2.5Cre/+ mediated Notch1 or Rbpjk deletion did not change the Hey2 expression pattern 
between the control and knockout at both E9.5 and E12.5 (Fig. 4a–d, Suppl. Figure 2a,b). We then quantified the 
number of Hey2 molecules within cells in different layers of the myocardium with the enrichment index of Hey2 
in different layers determined by their relative numbers of Hey2 molecules (Fig. 4a,e). We found that the intensity 
of Hey2 expression in the compact zone of the knockout is reduced compared to the control in both knockouts 
(Fig. 4a–e), while its intensity in other regions, such as endocardial cells, was not obviously affected (Fig. 4a–d). 
The Nkx2.5Cre/+; Rbpjkfl/fl heart showed slightly reduced Hey2 expression based on Q-PCR (Suppl. Figure 2c). We 
also examined whether the Notch1 deletion would disrupt the expression pattern of Hey2 in the compact and 
trabecular zone. The Hey2 expression pattern in the knockouts was compared to that of the controls by linear 
regression comparison, and we found that the expression pattern among the control and knockouts are not sig-
nificantly different based on the slopes (Fig. 4e,f). Consistently, when ex vivo cultured hearts were treated with 
DAPT, a γ-secretase inhibitor which prevents Notch activation, the expression pattern of Hey2 was not changed, 
although the level was slightly reduced (Data not shown). These data suggest that Notch signaling mildly regulates 
the expression level of Hey2, but not its expression pattern in the myocardium.
The Nrg1/ErbB2 pathway does not regulate Hey2 expression pattern. We were then interested 
in identifying the signaling pathways that regulate the expression pattern of Hey2 in the compact zone. Previous 
work has shown that global deletion of the receptors or ligand of the Nrg1/ErbB2,4 pathway abrogates trabec-
ular formation26–28. We used the Nkx2.5Cre/+ line to delete ErbB2 (Fig. 5a,b). The Nkx2.5Cre/+; ErbB2fl/fl knockout 
hearts displayed a lower proliferation rate and thinner compact zone (Data not shown). Previous work has shown 
that Notch1 signaling regulates cardiomyocyte differentiation through Nrg1/ErbB2,424. We hypothesized that 
Nrg1/ErbB2,4 might regulate Hey2 expression in the compact zone. We examined the expression of Hey2 in the 
Nkx2.5Cre/+; ErbB2fl/fl heart and found that the Hey2 expression level was slightly reduced (Suppl. Figure 3a), but 
its expression pattern and relative enrichment in the compact zone was not affected (Fig. 5c,d), suggesting that 
Nrg1/ErbB2,4 does not regulate the Hey2 expression pattern.
FGF signaling regulates Hey2 expression pattern in the ventricles temporally. The studies above 
showed that the signaling pathways such as Notch and Nrg1 signaling that regulate trabeculation and/or com-
paction control the expression levels but not the expression pattern of Hey2. Indeed, the signaling pathway that 
regulates Hey2 expression pattern in the myocardium is unknown. In other developmental processes, such as 
www.nature.com/scientificreports/
6ScIentIfIc REPORTs |  (2018) 8:2678  | DOI:10.1038/s41598-018-20917-w
somitogenesis, Notch regulates Hey219, while in the organ of Corti, FGF signaling regulates Hey2 expression via 
a Notch-independent mechanism to maintain pillar cell fate29. During cardiac development, FGF2, FGF9, and 
FGFR1 are the major fibroblast growth factors and receptor that are expressed in mouse and chick ventricles30–32. 
Fgfr1 and Fgfr2 cardiac-specific double knockout hearts show increased expression of sarcomeric actin and pre-
mature differentiation, indicating that FGF signaling functions to maintain the primitive status of cardiomyo-
blast32. Whether FGF signaling contributes to the relative immaturity of cardiomyocytes in the compact zone 
and more mature cardiomyocytes in the trabecular zone is not clear. Our RNAscope and immunofluorescence 
Figure 3. Notch signaling regulates Hey2 expression in ventricular endocardial cells. (a and b) N1ICD staining 
in control and Nfatc1cre; Notch1fl/fl hearts at E9.5 and E10.5. White arrows show reduced NICD expression in 
a knockout compared to control in a&b. (c and d) Hey2 expression in control and Nfatc1cre; Notch1fl/fl hearts 
at E9.5. Endocardial cells pointed by white arrows in d and d1 show reduced Hey2 expression compared to 
c&c1. (e and f) Hey2 expression in control and Nfatc1cre; Notch1fl/fl hearts at E10.5. Endocardial cells pointed 
by white arrows in f1 show reduced Hey2 expression compared to e1. (g and h) Hey2 expression in control and 
Tie2cre; Notch1fl/fl hearts at E9.5. White arrows in f1 and h1 indicate reduced expression of Hey2 in ventricular 
endocardial cells and AVC endocardial cells compared to their controls (e1 and g1). The box regions in (c–h) are 
zoomed to separate pictures that are labeled with the same name of the box. Scale bars in (a–h) are 100 μm and 
10 μm in zoomed boxes. Representative pictures from at least three embryos of each genotype at different ages 
were shown.
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Figure 4. Notch signaling in myocardium regulates the expression level but not the pattern of Hey2 in the 
myocardium. (a and b) Hey2 expression in E9.5 control and Nkx2.5cre; Notch1fl/fl hearts. The white numbers 
in a1 indicate the cell layers from the 1st to the 5th layer of ventricular myocardium and the number of Hey2 
expression in different layers were quantified and presented in (e). (c and d) Hey2 expression in E9.5 control 
and Nkx2.5cre; Rbpjkfl/fl hearts. The box regions in (a–d) are zoomed to separate pictures that are labeled with 
the same name of the box. (e) Hey2 enrichment index. The average number of Hey2 molecules from 10 cells 
from each layer was quantified, and their ratio to layer #1, which is considered as 1, was presented in (e) 
Quantification of Hey2 expression at different layers in Nkx2.5cre; Notch1fl/fl, and Nkx2.5 cre; RBPJkfl/fl hearts 
were shown. Expression level of Hey2 in different layer of cells of different genotypes were quantified and 
compared via student’s t-test. (f) The expression patterns of Hey2 in different treatments were analyzed by linear 
regression comparison and they were not significantly different from the control based on the lineage regression 
comparisons. Scale bars in (a–h) are 100 μm and 10 μm in zoomed box. Representative pictures from at least 
three embryos of each genotype or treatment at different ages were shown.
www.nature.com/scientificreports/
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staining show that Fgfr1 is expressed in the myocardium and endocardium (Suppl. Figure 4a). Considering that 
multiple FGF receptors and FGF ligands are expressed in the heart, as well as the redundant functions of these 
ligands and receptors, we examined the effects of FGF signaling on Hey2 expression pattern by stimulating the 
hearts with FGF2 in vivo and ex vivo, instead of using a loss-of-function approach33. Ex vivo cultured hearts 
treated with FGF2 ligand for 2 hours showed an increased expression of Hey2 compared to the control based 
on the number of Hey2 mRNAs per cell (Fig. 6a,b). The FGF2 treated hearts also showed enrichment of Hey2 in 
both outer compact and inner/trabecular zones compared to the control (Fig. 6b,c). We then further examined if 
FGF2 stimulation in vivo would increase the Hey2 expression level and change its expression pattern by injecting 
FGF2 at a concentration of 20ng/gram body weight to the pregnant females when the embryos were at E8.5. We 
found that FGF2 stimulation increased the expression of pAkt and pErk compared to the vehicle treated control 
(Suppl. Figure 4b–e), indicating an effective FGF2 stimulation. We then quantified the Hey2 expression level and 
examined the enrichment of Hey2 in the compact zone in both in vivo and ex vivo models. We found that FGF2 
stimulation increased the expression level of Hey2 and also changed the enrichment of Hey2 in the compact zone 
(Fig. 6c–f). The FGF2 induced expression pattern change was not maintained at later stages, as the Hey2 expres-
sion pattern in hearts treated by injecting FGF2 into the pregnant females for three consecutive days was not 
different from the expression pattern in vehicle treated controls. However, we did find that the FGF2 stimulation 
promotes trabeculation (Suppl. Figure 4f).
FGF2 regulates Hey2 expression level in a Notch1 dependent manner. We then used mouse 
embryonic fibroblasts (MEF) from ROSA26CreERT2; Notch1fl/fl embryos to further determine whether FGF2 and 
Notch1 regulate Hey2 expression level (Fig. 7a–d, Suppl. Figure 5). ROSA26CreERT2; Notch1fl/fl MEF cells were 
either treated with vehicle or 4-Hydroxytamoxifen (4-OHT) to delete Notch1. qRT-PCR and western blot analyses 
indicated that the deletion of Notch1 is efficient (Fig. 7a,c,d). We stimulated the control and Notch1 null MEFs 
with FGF2, and the stimulation resulted in the higher level of pErk as expected33 (Fig. 7c). We then determined 
whether FGF2 and Notch1 regulate the expression level of Hey2. Notch1 deletion decreased the expression of Hey2 
Figure 5. Nrg/ErbB2,4 pathway does not regulate Hey2 expression pattern. (a and b) ErbB2 deletion in 
Nkx2.5cre; ErbB2fl/fl at E9.5 indicated by the absence of ErbB2 immunostaining in the knockout. (c and d) Hey2 
expression in E9.5 control and Nkx2.5cre; ErbB2fl/fl hearts. The box regions in c,d are zoomed to separate pictures 
that are labeled with the same name of the box. Scale bars in (a–d) are 100 μm. Representative pictures from at 
least three embryos of each genotype were shown.
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based on Q-PCR and Western blot analyses (Fig. 7b–d). FGF2 stimulation promotes Hey2 expression in control 
MEF, but not in the Notch1 null MEF (Fig. 7b–d). These data suggest that Notch1 regulates Hey2 expression and 
FGF2 regulates Hey2 in a Notch1 dependent manner.
Discussion
Hey2 expression in endocardial cells of AVC, OFT and trabeculae might explain the valvular 
defects of Hey2 mutants. Hey2, Hey1, and HeyL comprise a subfamily of mammalian hairy/enhancer of 
split-related basic helix-loop-helix genes with a putative Drosophila homologue, dHey34, and a zebrafish homo-
logue, Gridlock11. Hey2 displays a spatiotemporal expression pattern and is expressed in the somite, heart, cran-
iofacial region, and nervous system at early embryonic stages34. Detailed examination of Hey2 expression in 
mouse heart shows that Hey2 is expressed in the ventricular septum and compact zone but not in the atrium at 
all. In this study, we used RNAscope and Hey2CreERT2 knockin mouse line to further characterize Hey2 expression 
level and pattern and found that Hey2 is also expressed in the endocardial cells of the AVC, OFT and at the base 
of trabeculae (Figs 1 and 2). With the RNAscope and immunofluorescent staining, we can infer that the expres-
sion of Hey2 detected in the cardiac OFT and aortic arch arteries1,34 was actually in the endothelial cells (Figs 1 
and 2). The expression pattern of Hey2 via Hey2CreERT2 knockin mouse line is consistent with the results from 
RNAscope. The expression of Hey2 in the endocardial cells of the AVC and OFT and mesenchymal cells derived 
from those endocardial cells might explain the atrioventricular valve defects, pulmonary stenosis, tetralogy of 
Fallot, and tricuspid atresia found in the Hey2 knockout mice7,8. The expression of Hey2 in the ventricles but not 
in atria might explain why the Hey2 knockouts display ectopic atrial gene expression in the myocardium12,13. 
Hey2 null cardiomyocytes display malformed mitochondria, abnormal accumulation of glycogen particles, and 
Figure 6. FGF signaling regulates Hey2 expression pattern in the ventricles temporally. (a and b) FGF2 
stimulation increases Hey2 expression in the inner compact zone as indicated by green arrows in the ex vivo 
cultured heart. (c) Quantification and comparison of Hey2 expression in cardiomyocytes at different layer of in 
vivo and ex vivo cultured E9.5 hearts with and without FGF2 stimulation. (d and e) FGF2 stimulation in vivo 
increases Hey2 expression in the inner compact zone as indicated by green arrows compared to the vehicle 
treated hearts. (f) Hey2 expression patterns of FGF2 stimulated hearts are significantly different from control 
hearts based on the linear regression comparison assay. Scale bars in (a–e) are 100 μm. Representative pictures 
from at least three embryos of each treatment were shown.
www.nature.com/scientificreports/
1 0ScIentIfIc REPORTs |  (2018) 8:2678  | DOI:10.1038/s41598-018-20917-w
disorganized myofibrils based on transmission electron microscope analysis8, suggesting that Hey2 might regulate 
cardiomyocyte differentiation and maturation, and is therefore critical for normal cardiac function. In summary, 
using RNAscope and Hey2CreERT2 knockin line, we have determined that the Hey2 expression pattern is broader 
than previously reported and the expression of Hey2 in the endocardial cells of the AVC and OFT might explain 
the variety of defects found in Hey2 knockout mice and human patients that bear Hey2 duplication or mutations.
Notch regulates Hey2 expression in endocardial cells. Despite Hey2’s high homology to other Hey 
family members18, the notion that Notch signaling regulates Hey2 expression is controversial. During mouse 
somitogenesis, Hey2 expression was altered in both the Dll1 and the Notch1 knockout mice19. NICD overexpres-
sion up-regulates Hey2 in an Rbpjk dependent manner in smooth muscle cells35, indicating that Notch signaling 
regulates Hey2 expression. However, in the heart, NICD overexpression activated Hey1 but not Hey2 expression 
in the NICD transgenic line20, the Notch2 knockout displayed a normal expression pattern of Hey1 and Hey221, 
and Rbpjk global knockout embryos did not alter the expression of Hey2 in the heart based on Q-PCR22. In 
Figure 7. FGF signaling regulates Hey2 expression in a Notch1 dependent manner. (a) Notch1 is deleted 
efficiently in ROSA26CreERT2; Notch1fl/fl MEFs via 4-OHT treatment. (b) Q-PCR analysis shows that Hey2 mRNA 
level is increased with FGF2 stimulation in control MEF cell and decreased in Notch1 null MEF cell, while FGF2 
stimulation doesn’t cause significant change in Notch1 null MEFs compared with control based on student’s 
t-test. (c and d) Notch1 is deleted efficiently in ROSA26CreERT2; Notch1fl/fl MEFs by 4-OHT treatment. p-Erk 
protein level decreased in Notch1 null MEFs. FGF2 stimulation increases p-Erk protein level in control MEFs 
but not in Notch1 null MEFs. FGF2 stimulation promoted Hey2 protein level in control MEFs but not Notch1 
null MEFs. An unpaired, two-tailed student’s t-test was used for statistical comparison. The Representative 
pictures from three repeats were shown and the original pictures of all the blots are shown in Suppl. Figure 5.
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addition, in the Numb and Numblike double knockout heart, in which Notch signaling was upregulated based 
on a Notch transgenic reporter and N1ICD protein levels36–38, there was no obvious Hey2 up-regulation based 
on mRNA deep sequencing and Q-PCR. These reports suggest that Notch does not regulate Hey2 in the heart. 
However, it is possible that Notch regulates Hey2 expression in some cell types that cannot be detected by total 
RNA in the heart or by traditional ISH. In this study, equipped with RNAscope coupled with immunofluores-
cence staining, we clearly demonstrated that Hey2 is expressed in endocardial cells as we discussed above. We 
used Nfatc1Cre or Tie2Cre to delete Notch1 or Rbpjk in the endocardial cells and found that Hey2 expression was 
reduced in endocardial cells that burrowed into the myocardium and closely contacted the cardiomyocytes. The 
expression of Hey2 in the endocardial cells of the AVC but not of the OFT was slightly reduced in the knockout 
compared to the control, indicating that Notch signaling at least partially regulates Hey2 in the endocardial cells 
of the AVC and those that contact the myocardium. This is consistent with the report that Notch1 is required for 
proper development of the semilunar valves and cardiac outflow tract39,40. Furthermore, the Hey2 expression 
in the endocardial cells attached to the myocardium or at the base of the trabecula is higher than that of other 
endocardial cells, which is consistent with the previous report that NICD is highly expressed in the endocardial 
cells at the base of the trabecula24. The Hey2 expression in these endocardial cells and its potential to be a target of 
Notch signaling might explain the trabeculation defect of the Hey1 and Hey2 double knockout41. Also, the higher 
expression of Hey2 and NICD in the endocardial cells attached to cardiomyocytes24 indicates a potential Notch 
signaling pathway from myocardium to endocardium; however, further work needs be done to identify the Notch 
ligand that regulates Hey2 expression in the endocardial cells.
Hey2 is essential for cardiomyocyte maturation in the left ventricle. The essential functions of 
Hey2 in the heart are revealed by the Hey2 loss of function studies. The Hey2 null hearts display a dilated left ven-
tricular chamber with markedly diminished fractional shortening of the left ventricle8. Hey2 null cardiomyocytes 
displayed abnormal mitochondria, abnormal accumulation of glycogen particles, and disorganized myofibrils 
based on transmission electron microscope analysis8. Hey2 knockouts show ectopic expression of Tbx5, ANF, and 
Cx40 in the compact zone12,13. Furthermore, the expression levels of β-MHC and ANF genes in the Hey2 knock-
out are increased8,12, suggesting that Hey2 is required to repress atrial gene expression and to maintain ventricular 
identity. Other studies show that Hey2 null cardiomyocytes display altered action potentials and mild conduction 
system expansion42, and Hey2 null cardiomyocytes display defective myocardial calcium release and diminished 
fractional shortening in the setting of normal calcium stores and calcium sensitivity43. It was also reported that 
the Hey1 and Hey2 double knockout displayed a trabeculation defect41, and that Hey1 and Hey2 might function 
redundantly to prevent trabecular cardiomyocyte apoptosis41. These studies indicate that Hey2 might be involved 
in cardiomyocyte maturation during heart development. However, the functions of Hey2 enrichment in the com-
pact zone but not in the trabecular zone remain unknown.
Pathways that regulate asymmetric distribution of Hey2 to compact zone and trabecular zones 
are unknown. Trabecular and compact cardiomyocytes display different features with trabecular cardiomy-
ocytes exhibiting a lower proliferation rate and being more molecularly mature than cardiomyocytes of the com-
pact zone44. Trabecular and compact zones can be distinguished by the differential expression of many genes. For 
example, p57, Irx3, BMP10, Sphingosine 1-phosphate receptor-1 and Cx40 are highly expressed in the trabecular 
zone, while Tbx20, Hey2, and N-Myc are highly expressed in the compact zone14,15,45–48. Our previous work has 
shown that asymmetric expression of Hey2 and Bmp10 occurs after but not before cytokinesis in perpendicularly 
oriented cell division, and that their asymmetric distributions are due to the differences in geometric location 
between the two daughter cells15. The daughter cell closer to cardiac jelly displays less Hey2 and more BMP10 
compared to the other daughter cell that is relatively closer to the surface of the heart, indicating that potential 
instructive cues for trabecular regional specification might lie in the cardiac jelly and endocardium15. Indeed, the 
signaling pathway that regulates the asymmetric distribution of Hey2 or other genes between the two zones is 
unknown. We have showed that Numb Family Proteins regulate Irx3 expression pattern in the heart, but whether 
Numb also regulates Hey2 is not clear36,37. Previous work has shown that at later stages, direct Notch ligand/recep-
tor interactions might be involved in the regulation of trabecular cardiomyocyte differentiation, as overexpression 
of glycosyltransferase manic fringe in the endocardium can cause abnormal expression patterns of Hey2 at later 
gestation stage49. However, the deletion of Notch1 or Rbpjk at early stage in endocardial cells or myocardium dur-
ing trabecular formation did not affect Hey2 asymmetric distribution. Surprisingly, the signaling pathways that 
regulate trabecular initiation, including NRG1/ErbB2,426-28, Notch signaling24, Hand225 and YAP50,51, regulate 
the expression level of Hey2, but not the expression pattern of Hey2. This indicates that trabecular initiation and 
trabecular specification are two different processes and are regulated by different pathways. Instead, we found that 
FGF2 stimulation regulates Hey2 asymmetric distribution in myocardium, and results in over-trabeculation, but 
the mechanisms of how FGF2 regulates Hey2 and trabeculation will need further studies.
Methods
Experimental animals. Mouse strains Notch152 was purchased from Jackson Lab. Nfatc1Cre/+, which is spe-
cifically expressed in the endocardial cells23, was used to delete Notch152 and Rbpjk53 in endocardial cells. Tie2-
Cre54, which is specifically expressed in endothelial cells, was used to delete Notch1 and Rbpjk in endothelial 
cells. Nkx2.5Cre/+ mice55, a gift from Dr. Robert Schwartz, were used to delete Rbpjk, Notch1 and ErbB256. Male 
heterozygous with Nkx2.5Cre/+ were setup to cross homozygous females to generate knockouts, e.g., Nkx2.5Cre/+; 
Notch1fl/+ males were mated to Notch1fl/fl females to generate Nkx2.5Cre/+; Notch1fl/fl. Their sibling embryos were 
designated as controls. Dr. Bin Zhou at Shanghai Institutes, Chinese Academy of Sciences, Shanghai, China, pro-
vided the Hey2CreERT2 mouse17. To isolate embryos, the pregnant females at the specified age will be euthanized by 
CO2 inhalation and cervical dislocation. CO2 with a filling rate of about 20% of the chamber volume per minute 
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was added to the existing air in the chamber to achieve a balanced gas mixture to fulfill the objective of rapid 
unconsciousness with minimal distress to the animals. All animal experiments were approved by the Institutional 
Animal Care and Use Committee (IACUC) at Albany Medical College and performed according to the NIH 
Guide for the Care and Use of Laboratory Animals.
RNAscope: In Situ hybridization and immunofluorescence staining. In Situ hybridization 
(ISH) and immunofluorescence staining (IFS) were performed according to the protocol of the RNAscope® 
Chromogenic (RED) Assay (Cat. No. 310036), which can detect single mRNA molecules15. Briefly, 24 hours after 
fixation, the embryos were frozen embedded in OCT compound. Sections of the frozen embedded samples were 
processed following the step-by-step protocol of the kit. The expressional level of mRNA in each cell was based 
on the number of mRNA molecules or signal intensity detected using the confocal scanned pictures, and three 
sections for each genotype were quantified. The number of mRNA molecules in cells at comparable locations was 
also quantified, and only the control and knockout samples that came from the same litter and underwent the 
same experiments were quantified and compared.
Quantification of Hey2 mRNA molecules in cardiomyocytes at different layers. Cardiomyocytes 
at different layers starting from the outer compact layer, to the inner compact zone and trabecular zone were 
selected to quantify the number of Hey2 molecules. For each sample, we quantified 3 sections, and for each 
section, 12 cells at 3 different regions per layer were quantified. The mean value of the 36 cells in each layer was 
presented. Only control and mutants that came from the same litter and underwent the same experiments were 
quantified and compared. Each experiment was repeated three times.
MEFs isolation and western blot analysis. Mouse embryonic fibroblasts (MEF) were isolated from 
E13.5-E14.5 embryos with the genotype of Notch1fl/fl; ROSA26CreERT2. Cultured MEFs were infected treated with 4-OHT 
as indicated in different experiments for 36 hours, and then starved with serum free medium overnight. The cells were 
then stimulated with FGF2 ligand for 15 minutes. After the stimulation, the cell lysate was harvested. Lysates from 
MEFs of different genotypes and treatment were processed for western blot. Antibodies used for western blots were 
listed above. The experiments were repeated three times and quantification data was shown in the figure.
Paraffin and frozen section immunohistochemistry (IHC). Immunohistochemistry (IHC) and 
Immunofluorescence (IF) were performed as previously published57–59. The following primary antibodies were 
used: BrdU (1:50, Becton Dickinson, 347583), PECAM (1:50, BD Pharmingen), MF20 (1:100, Developmental 
Studies Hybridoma Bank (DSHB)), NICD (1:50, Cell Signaling, 4147 S), ErbB2 (1:100, Cell Signaling, 2165 S), 
ESR (Abcam, pre-diluted), Endomucin (1:50, SCBT), p-Akt (1:50, Cell Signaling, 9271 S) and p-Erk (1:100, Cell 
Signaling, 4376 S).
Ex vivo culture system. The ex vivo culture protocol was developed by Dr. C.P. Cheng and was utilized as 
reported36. Briefly, embryos lacking the head and tail were cultured in medium containing FGF2 at 2ng/gram 
body weight or vehicle for 2 hours. Then, the embryos were fixed and used for RNAscope.
Imaging. The following systems were used: for confocal imaging, Zeiss LSM880-META NLO confocal 
microscope equipped with Airyscan; for color imaging, Zeiss Observer Z1 with a Hamamatsu ORCA-ER cam-
era; for fluorescence imaging, Zeiss Observer Z1 with an AxioCam MRm camera. All histology analysis and 
immune-fluorescent staining analysis were quantitated in a blinded way by at least two investigators.
Statistics. Data is shown as mean ± standard deviation. An unpaired, two-tailed student’s t-test or linear 
regression comparison as specified were used for statistical comparison. A P-value of 0.05 or less was considered 
statistically significant.
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